MEDPLUS

Medplus Health Services Limited

Medplus Health Services Limited has announced the outcome of its board meeting, where it approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a limited review report. The company also approved CAPEX plans for setting up a food park and a concierge health and wellness services facility, and appointed a new company secretary and compliance officer.

Medplus Health Services Limited

MedPlus Health Services Limited has received a suspension order for a Drug License of a store situated in Karnataka due to a two-day suspension under Rule 65 of the Drugs and Cosmetics Act, 1940, resulting in a potential revenue loss of Rs 0.53 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited has announced earnings calls for the quarter ended June 30, 2026, as per SEBI regulations.

Medplus Health Services Limited

MedPlus Health Services Limited has received three suspension orders for drug licenses of its subsidiary Optival Health Solutions Private Limited in the state of Karnataka, resulting in potential revenue loss of Rs 0.77 lacs, Rs 0.35 lacs, and Rs 0.47 lacs respectively.

Medplus Health Services Limited

MedPlus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license of a store in Maharashtra, which may impact revenue.

Medplus Health Services Limited

Medplus Health Services Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, stating that the details of securities dematerialized/rematerialized have been furnished to all the stock exchanges where the shares are listed.

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange about General Updates, specifically a suspension order for a Drug License of a store situated in the state of Bangalore, resulting in a potential revenue loss of Rs 5.13 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has received a two-day suspension order for a drug license for a store in Karnataka, resulting in a potential revenue loss of Rs 0.80 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited has informed that its subsidiary Optival Health Solutions Private Limited has received two suspension orders for a Drug License of a store situated in the state of Karnataka, resulting in potential revenue loss of Rs 0.32 lacs and Rs 0.47 lacs.

Medplus Health Services Limited

MedPlus Health Services Limited has received three suspension orders for a Drug License of its subsidiary Optival Health Solutions Private Limited, resulting in a potential revenue loss of Rs 0.22 lacs, Rs 0.60 lacs, and Rs 0.76 lacs for one, two, and three days respectively.

Medplus Health Services Limited

MedPlus Health Services Limited has received a one-day suspension order for a drug license of a store in Karnataka due to a violation of the Drugs and Cosmetics Act, resulting in a potential revenue loss of Rs 0.46 lacs.

Medplus Health Services Limited

Medplus Health Services Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Medplus Health Services Limited

MedPlus Health Services Limited has received two suspension orders for a Drug License of a store situated in the state of Andra Pradesh. The suspension is for seven days and may impact the company's revenue by Rs 1.92 lacs and Rs 1.00 lacs respectively.

MEDPLUS

MedPlus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a Drug License. This order pertains to one of its stores located in the state of Maharashtra. The suspension means the affected store cannot operate, representing an operational disruption for the subsidiary. This update was provided to the exchanges under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

MEDPLUS

MedPlus Health Services Limited announced a regulatory update regarding its subsidiary, Optival Health Solutions Private Limited. The subsidiary has received a suspension order for the Drug License of one of its stores. This specific store is located in the state of Telangana. For investors, this indicates a minor operational disruption due to a regulatory action affecting a single retail outlet within the company's wider network.

Medplus Health Services Limited

Medplus Health Services Limited announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license. This suspension pertains to a single store located in the state of Telangana. The company disclosed this update in compliance with SEBI listing regulations. While specific financial figures are not provided, the impact on investors is likely minimal given it involves only one store's license.